Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications is a research paper published in Journal of Clinical Oncology (2024). On theSindex it has a DataRank of 0.505. It has been cited 28 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.505
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5P01CA225517-02
Immunobiology and Immune Therapy for Merkel Cell Carcinoma
National Institutes of Health
Grant: 5K24CA139052-07
Pathogenetic and prognostic studies for improved therapy of Merkel cell carcinoma
National Institutes of Health
Grant: 5R01CA162522-02
Humoral and cellular immunity in polyomavirus-linked Merkel cell carcinoma
NCI NIH HHS
Grant: K24 CA139052
NCI NIH HHS
Grant: P01 CA225517
NCI NIH HHS
Grant: R01 CA162522
Fields of Study
MeSH Terms
Keywords